These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19907721)

  • 41. Plasma endothelin-1 and cardiovascular risk among young and healthy adults.
    Bossard M; Pumpol K; van der Lely S; Aeschbacher S; Schoen T; Krisai P; Lam T; Todd J; Estis J; Risch M; Risch L; Conen D
    Atherosclerosis; 2015 Mar; 239(1):186-91. PubMed ID: 25617859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals.
    Leyva F; Wingrove C; Felton C; Stevenson JC
    Metabolism; 1997 Oct; 46(10):1137-9. PubMed ID: 9322795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls.
    Yu HH; Joubran R; Asmi M; Law T; Spencer A; Jouma M; Rifai N
    Clin Chem; 2000 Feb; 46(2):258-64. PubMed ID: 10657383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma levels of von willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease.
    Wojakowski W; Gmiński J
    Scand J Clin Lab Invest; 2001 Jul; 61(4):317-23. PubMed ID: 11465346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma endothelin-1 concentrations during cold exposure in essential acrocyanosis.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS; Tamburino G
    Angiology; 1996 Nov; 47(11):1033-8. PubMed ID: 8921751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The homocysteine distribution: (mis)judging the burden.
    de Bree A; Verschuren WM; Blom HJ; de Graaf-Hess A; Trijbels FJ; Kromhout D
    J Clin Epidemiol; 2001 May; 54(5):462-9. PubMed ID: 11337208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma homocysteine levels in Indian patients with essential hypertension and their siblings.
    Jain S; Ram H; Kumari S; Khullar M
    Ren Fail; 2003 Mar; 25(2):195-201. PubMed ID: 12739826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of plasma total homocysteine concentrations in the healthy Iranians.
    Golbahar J; Rezaian G; Bararpour H
    Clin Biochem; 2004 Feb; 37(2):149-51. PubMed ID: 14725947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin-1 in acute renal failure.
    Peco-Antić A; Nastić-Mirić D; Popović-Rolović M; Adanja G; Kostić M; Paripović V
    Ren Fail; 1996 Jul; 18(4):553-6. PubMed ID: 8875679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exaggerated endothelin release in response to acute mental stress in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Attinà T; Messina R; Fiore CE
    Angiology; 2002; 53(4):383-90. PubMed ID: 12143942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of an immunoassay for measurement of plasma total homocysteine.
    Marangon K; O'Byrne D; Devaraj S; Jialal I
    Am J Clin Pathol; 1999 Dec; 112(6):757-62. PubMed ID: 10587697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The level of circulating PGC1a in cardiovascular disease].
    Zhloba AA; Subbotina TF; Alekseevskaya ES; Moiseeva OM; Gavrilyuk ND; Irtyuga OB
    Biomed Khim; 2016; 62(2):198-205. PubMed ID: 27143380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Value of the laboratory markers of endothelial damage in unstable angina pectoris].
    Smirnova VIu
    Klin Lab Diagn; 2009 Aug; (8):9-10. PubMed ID: 19824404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. About-half-weekly (circasemiseptan) component of the endothelin-1 (ET-1) chronome and vascular disease risk.
    Tarquini B; Cornélissen G; Perfetto F; Tarquini R; Halberg F
    Peptides; 1997; 18(8):1237-41. PubMed ID: 9396067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Markers of the course of obliterating atherosclerosis of lower limb arteries].
    Kalinin RE; Suchkov IA; Chobanian AA; Nikiforov AA; Dmitrieva MN; Isakov SA
    Angiol Sosud Khir; 2021; 27(2):17-24. PubMed ID: 34166340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma endothelin-1 levels and circulating endothelial cells in patients with aortoarteritis.
    Dang A; Wang B; Li W; Zhang P; Liu G; Zheng D; Ruan Y; Liu L
    Hypertens Res; 2000 Sep; 23(5):541-4. PubMed ID: 11016811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ENDOTHELIAL DYSFUNCTION IN ACROMEGALIC PATIENTS: A CASE-CONTROL STUDY.
    Ghiorghe S; Dragomir A; Bartos D
    Acta Endocrinol (Buchar); 2018; 14(3):384-388. PubMed ID: 31149287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical view on: Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes.
    Kayadibi H; Sertoglu E; Uyanik M
    Diabetol Metab Syndr; 2015; 7():22. PubMed ID: 25798200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A view at the future--a dynamical, protocol-based and computationally intensive approach in cardiovascular risk assessment.
    Majnarić-Trtica L; Vitale B; Martinis M; Reiner Z
    Coll Antropol; 2010 Jun; 34(2):437-45. PubMed ID: 20698115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Keeping the genie in the bottle: growth hormone and cardiovascular disease.
    de Lemos JA; Vigen R
    J Am Coll Cardiol; 2014 Oct; 64(14):1461-3. PubMed ID: 25277617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.